SELENBP1 and breast carcinoma: The data from Wulfkuhle et al. shows that SELENBP1 was the most downregulated protein (more than 46 fold) in whole and/or laser capture microdissected tumor tissues of breast cancer patients by proteomic analysis in two-dimensional gel electrophoresis and MS sequencing [35].